Learn more

EISAI R & D MANAGEMENT CO LTD

Overview
  • Total Patents
    108
  • GoodIP Patent Rank
    210,990
  • Filing trend
    0.0%
About

EISAI R & D MANAGEMENT CO LTD has a total of 108 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2002. It filed its patents most often in Australia and Ecuador. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ACETYLON PHARMACEUTICALS INC, MITSUBISHI PHARMA CORP and MERCK PATENT GES MIT BESCHRÄNKTER HAFTUNG.

Patent filings in countries

World map showing EISAI R & D MANAGEMENT CO LTDs patent filings in countries
# Country Total Patents
#1 Australia 107
#2 Ecuador 1

Patent filings per year

Chart showing EISAI R & D MANAGEMENT CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Ito Koichi 11
#2 Sato Nobuaki 9
#3 Kaneko Toshihiko 9
#4 Takaishi Mamoru 8
#5 Takahashi Keiko 7
#6 Kamada Atsushi 7
#7 Matsushima Tomohiro 7
#8 Kawano Koki 7
#9 Kitazawa Noritaka 7
#10 Doi Eriko 6

Latest patents

Publication Filing date Title
AU2013203117A1 Methods for prognosing the ability of a zearalenone analog compound to treat cancer
AU2009213488A1 Bicycloamine derivative
AU2009210098A1 Combined use of angiogenesis inhibitor and taxane
AU2009203368A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases
AU2008290001A1 Novel preparation for external use
AU2008202882A1 Immunological adjuvant compound
AU2008246717A1 Method for production of tablet
AU2007251896A1 Neurocyte protective agent
AU2007216681A1 Methods of screening for compounds that inhibit the biosynthesis of GPI in malaria parasites
AU2007285215A1 Stable lyophilized preparation
AU2006309551A1 Use of combination of anti-angiogenic substance and c-kit kinase inhibitor
AU2006300492A1 Process for producing 1-benzyl-4-[(5,6-dimethoxy-1indanon)-2-yl]methylpiperidine or hydrochloride thereof
AU2006250495A1 A method of marking a composition for use in oral administration
AU2006210810A1 Crystalline 1H-imidazo[4,5-b]pyridin-5-amine,7-[5-[(cyclohexylmethylamino)-methyl]-1H-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses
AU2005283422A1 Medicinal composition
AU2005265443A1 DNA coding for polypeptide participating in biosynthesis of pladienolide
AU2005207786A1 Method of stabilizing macrolide compound